HypeCheck

Updated · AI-assisted evidence analysis

Wild Alaskan Salmon Oil for Dogs — Pure Liquid 32oz Review 2026: What Does the Evidence Show?

Salmon oil's omega-3 has dog evidence, but this bottle's claims run ahead — Overhyped

Share: Post Share

Claims vs Evidence

4 claims assessed. Support depends on the study results, formulation, and population. Matching an ingredient or dose alone does not establish a benefit.

"Visibly reduces itching, shedding and dry skin, with results in as little as 3-4 weeks" Stretch

Ingredient-level evidence for itch is partial. It comes from trials in dogs with allergic skin disease, lasting 6 to 16 weeks, with 16 to 29 dogs each. Shedding, dry skin and a 3-4 week onset weren't shown in the retrieved studies. No exact-product trial was found in this search.

Source: Double-blinded Crossover Study with Marine Oil Supplementation Containing High-dose icosapentaenoic Acid for the Treatment of Canine Pruritic Skin Disease. →

Marine oil with high-dose EPA in canine pruritic skin disease (crossover)

Double-blinded crossover, randomized, corn oil control · ingredient

Versus corn oil, marine oil significantly improved pruritus, alopecia and coat character. Shedding and dry skin not reported in the abstract.

Limitations: Small sample, itchy dogs only, abstract only, capsule product, onset before 6 weeks not reported

Species
dog
Participants / condition
16 dogs that completed, with idiopathic pruritus, confirmed atopy and/or flea allergy
Formulation
Marine oil capsule (1 ml; 180 mg EPA and 120 mg DHA), a different product from this liquid
Studied amount, not dosing advice
1 capsule per 4.55 kg daily (about 66 mg/kg EPA+DHA, calculated from reported figures)
Duration
6 weeks per arm, 3-week washout
Funding / conflicts
Not reported in the abstract
Study source ↓
PUFA and oclacitinib dose in atopic dogs

Placebo-controlled, double-blind trial · ingredient

Oclacitinib dose fell more with fish oil. Itch score was lower at day 112 and quality of coat improved only in the fish oil group. Skin lesion score (CADESI-04) did not change or differ between groups.

Limitations: Small, dogs on a concurrent drug, abstract only, lesion scores unchanged

Species
dog
Participants / condition
22 client-owned dogs with atopic dermatitis receiving oclacitinib
Formulation
A fish oil product (composition not reported in abstract) versus paraffin oil
Studied amount, not dosing advice
EPA+DHA amount not reported in the abstract
Duration
16 weeks
Funding / conflicts
Not reported in the abstract
Study source ↓
Omega-3 fatty acids in canine atopic dermatitis

Double-blinded, placebo-controlled, randomized trial · ingredient

Clinical scores improved with flax oil and with the EPA/DHA preparation, not placebo. Fatty acid intake did not correlate with clinical scores.

Limitations: Small, atopic dogs only, abstract only, benefit not tied to dose

Species
dog
Participants / condition
29 dogs with atopic dermatitis
Formulation
Flax oil or a commercial EPA/DHA preparation versus mineral oil; not this product
Studied amount, not dosing advice
Flax oil 200 mg/kg/day, or EPA 50 mg/kg/day plus DHA 35 mg/kg/day
Duration
10 weeks
Funding / conflicts
Not reported in the abstract
Study source ↓
"Supports joints, joint comfort and mobility" Partial

The ingredient record for EPA+DHA in arthritic dogs is graded supported. This label's amount can't be compared with the studied per-kg dose, and trials used arthritic dogs, often fish-oil foods, not a liquid oil for general support. No exact-product trial was found in this search.

Source: A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. →

EPA and DHA in dogs with osteoarthritis, placebo-controlled

Prospective, randomized, double-blind, placebo-controlled · ingredient

Discomfort, lameness and joint severity at day 84 and blood fatty acid measures improved significantly versus placebo. No major side effects.

Limitations: Abstract only; effect sizes and owner-versus-vet assessment details not available

Species
dog
Participants / condition
78 client-owned dogs with osteoarthritis of hip and/or stifle (74 completed)
Formulation
Triglyceride n-3 oil versus placebo oil; not this product
Studied amount, not dosing advice
Average 69 mg EPA+DHA/kg/day
Duration
84 days
Funding / conflicts
Funder not named in the abstract; listed as non-US government research support
Study source ↓
Fish oil omega-3 and weight bearing in dogs with osteoarthritis

Randomized, double-blinded, controlled trial · ingredient

Peak vertical force rose 5.6% with test food versus 0.4% with control; 82% versus 38% of dogs improved. Investigators saw better lameness and weight bearing.

Limitations: Small, short-term, food rather than supplement, abstract only

Species
dog
Participants / condition
38 client-owned dogs with osteoarthritis at 2 university clinics
Formulation
Food containing 3.5% fish oil omega-3 versus typical commercial food; a diet, not an oil topper
Studied amount, not dosing advice
3.5% fish oil omega-3 in food; daily EPA+DHA not stated
Duration
90 days
Funding / conflicts
Not reported in the abstract
Study source ↓
Fish oil omega-3 and carprofen dose in dogs with osteoarthritis

Randomized, controlled, multisite clinical trial · ingredient

Carprofen dose fell faster in dogs fed the supplemented diet.

Limitations: Outcome is drug dose, not a direct mobility measure; dogs on carprofen; abstract only

Species
dog
Participants / condition
131 client-owned dogs with stable chronic osteoarthritis on carprofen, 33 US clinics
Formulation
Fish-oil-supplemented food versus low-omega-3 control food
Studied amount, not dosing advice
Daily EPA+DHA not reported in the abstract
Duration
12 weeks
Funding / conflicts
Not reported in the abstract
Study source ↓
Omega-3 food and osteoarthritis in dogs, multicenter practice trial

Randomized, double-blinded, controlled clinical trial · ingredient

Owners reported better ability to rise and play at 6 weeks and to walk at 12 and 24 weeks versus control. Serum omega-3 rose.

Limitations: Food rather than supplement, owner-reported outcomes, abstract only

Species
dog
Participants / condition
127 client-owned dogs with osteoarthritis from 18 veterinary clinics
Formulation
Food high in fish oil omega-3 fatty acids versus typical commercial food; a diet, not an oil topper
Studied amount, not dosing advice
Total omega-3 content 31-fold higher than control food; daily EPA+DHA not stated
Duration
6 months, with assessments at 6, 12 and 24 weeks
Funding / conflicts
Not reported in the abstract
Study source ↓
"Supports heart, brain (cognitive function) and immune health" No evidence found

No applicable dog study of heart, cognitive or immune outcomes was retrieved for this oil or its ingredients. The searches focused on joints and skin, so this is a gap in what we reviewed, not a finding of no benefit.

Source: Wild Alaskan Salmon Oil for Dogs — Pure Liquid 32oz: manufacturer product page →

"Gives a smoother, shinier, healthier coat and relief from hot spots" Stretch

Coat scores improved with marine or fish oil in trials of 16 and 22 itchy dogs, so the ingredient record is partial. Hot spots weren't studied and no healthy-dog coat trial was found. No exact-product trial was found in this search.

Source: Double-blinded Crossover Study with Marine Oil Supplementation Containing High-dose icosapentaenoic Acid for the Treatment of Canine Pruritic Skin Disease. →

Marine oil and coat character in itchy dogs

Double-blinded crossover, randomized, corn oil control · ingredient

Coat character improved significantly over time and versus corn oil. Hot spots not reported.

Limitations: Small, itchy dogs only, abstract only

Species
dog
Participants / condition
16 dogs with idiopathic pruritus, atopy and/or flea allergy
Formulation
Marine oil capsule (180 mg EPA, 120 mg DHA); not this product
Studied amount, not dosing advice
1 capsule per 4.55 kg daily (about 66 mg/kg EPA+DHA, calculated)
Duration
6 weeks per arm
Funding / conflicts
Not reported in the abstract
Study source ↓
PUFA and coat quality in atopic dogs on oclacitinib

Placebo-controlled, double-blind trial · ingredient

Quality of coat improved only in the fish oil group (p = 0.041); skin lesion score unchanged.

Limitations: Small, concurrent drug, abstract only

Species
dog
Participants / condition
22 dogs with atopic dermatitis on oclacitinib
Formulation
Fish oil product (composition not reported in abstract) versus paraffin oil
Studied amount, not dosing advice
EPA+DHA amount not reported in the abstract
Duration
16 weeks
Funding / conflicts
Not reported in the abstract
Study source ↓

Signals

  • The page says every batch is tested and the oil is mercury-free, but no lab name, certificate or results appear in the reviewed material.
  • The claim of exceeding Proposition 65 and US and European Pharmacopeia standards comes with no supporting document in the reviewed material.
  • "Human grade" and "GMP certified facility" are manufacturer statements; no certificate or named auditor was shown.
  • The ingredient line says 100% wild caught Alaskan salmon, while the description says a salmon and pollock oil blend.
  • The page prints EPA (515 mg) and DHA (325 mg) per 5 ml serving.
  • The page gives pump-based serving instructions by dog weight.

Dose vs studies

Label amounts at the label's daily directions, per kg of body weight, compared with what dogs studies used. This compares the label with research. It is not dosing advice.

EPA + DHA Not comparable

Label: 840 mg per chew

Studied: 69 mg/kg/day EPA+DHA

The label gives no dosing table by weight.

Evidence checks

Species and formulation relevance

All evidence rows are dog studies of EPA/DHA or fish oil as an ingredient, in arthritic or itchy dogs. They used other products, capsules or fish-oil foods. No exact-product trial of this salmon and pollock oil was found in this search (pmid27269707, pmid34645070).

Label transparency

The page prints EPA and DHA per 5 ml serving and gives pump instructions by weight. The structured label data lists the amounts 'per chew', which doesn't fit a liquid. The dose check was 'not comparable' to the 69 mg/kg/day studied, so no within-range or below-range call is made. The ingredient line omits pollock.

Independent quality testing

Image text calls the product 'third-party tested', but no lab, seal, certificate or results were shown in the reviewed material. No quality-standard record (such as an NASC seal) was supplied. Whether independent verification exists is unknown from this review.

Study funding and detail

Most dog sources were abstracts only, so funders, effect sizes and amounts were often unavailable. The cited trials enrolled 16 to 131 dogs and ran 6 to 24 weeks (pmid34645070, pmid20187817, pmid20043800).

Sources (8)

  1. 1. Wild Alaskan Salmon Oil for Dogs — Pure Liquid 32oz: manufacturer product page →

    Manufacturer · Accessed 2026-11-04

  2. 2. Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. →

    Study · Accessed 2026-11-04

  3. 3. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. →

    Study · Accessed 2026-11-04

  4. 4. A multicenter study of the effect of dietary supplementation with fish oil omega-3 fatty acids on carprofen dosage in dogs with osteoarthritis. →

    Study · Accessed 2026-11-04

  5. 5. A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. →

    Study · Accessed 2026-11-04

  6. 6. Effect of omega-3 fatty acids on canine atopic dermatitis. →

    Study · Accessed 2026-11-04

  7. 7. Double-blinded Crossover Study with Marine Oil Supplementation Containing High-dose icosapentaenoic Acid for the Treatment of Canine Pruritic Skin Disease. →

    Study · Accessed 2026-11-04

  8. 8. A placebo-controlled, double-blind study evaluating the effect of orally administered polyunsaturated fatty acids on the oclacitinib dose for atopic dogs. →

    Study · Accessed 2026-11-04

How this report was produced

AI-assisted evidence analysis. We reviewed published material, not physical products.

Automated source and evidence checks completed on 2026-11-04. These checks are not veterinary review.

Research scope and outstanding checks

Searches covered dog osteoarthritis and nutraceutical reviews, the NuLife product name, and salmon or pollock oil with osteoarthritis, plus skin and coat ingredient records. Most sources were abstracts only. The search was not exhaustive and did not target heart, brain, immune, shedding or hot-spot outcomes. Not used as dog evidence rows: mixed dog and cat reviews (pmid36142319, pmid22404506), a guideline (pmid37601753), a collagen peptide trial (pmid39298537), a combination supplement with nucleotides and in vitro human cell work (pmid38474135), and trials of borage-plus-fish-oil blends or enriched diets.

Focused research searches:

  • (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
  • (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
  • (NuLife AND Wild AND Alaskan AND Salmon AND Oil) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
  • (NuLife AND Wild AND Alaskan AND Salmon AND Oil) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
  • (TITLE_ABS:Wild AND TITLE_ABS:Alaskan AND TITLE_ABS:salmon AND TITLE_ABS:oil AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
  • (TITLE_ABS:Wild AND TITLE_ABS:Alaskan AND TITLE_ABS:salmon AND TITLE_ABS:oil AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
  • (TITLE_ABS:Pollock AND TITLE_ABS:oil AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
  • (TITLE_ABS:Pollock AND TITLE_ABS:oil AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
  • An exact-product trial of this salmon and pollock oil in dogs
  • Dog research on heart, cognitive or immune outcomes
  • Shedding and hot-spot trials, and healthy-dog coat trials
  • A per-kg EPA+DHA comparison for this label's pump serving
  • Lab names, certificates or batch results for purity and heavy metals
  • Funding and conflict details for abstract-only studies

More dog supplements reviews

Check another product
Paste a product page to request an automated evidence review.